Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Extracellular vesicles from tracheal aspirates as novel biomarkers for bronchopulmonary dysplasia

FY 2023-24

Summary
Premature infants have underdeveloped lungs, so supplemental oxygen and mechanical ventilation are required to keep them alive. These life-saving interventions cause inflammation and tissue damage in the lungs. This leads to bronchopulmonary dysplasia (BPD), a chronic lung disease of prematurity for which there are no effective treatments. Mesenchymal stromal cells (MSCs) are a type of adult stem cell that are investigated for their therapeutic effect in many diseases. Studies in animals like mice, rats, and pigs have shown that MSCs are safe, work well, and improve lung injury in models of BPD. The HULC-1 trial (Helping Underdeveloped Lungs with Cells-1) evaluates the safety and feasbility of mesenchymal stromal cells (MSCs) for prevention of BPD. MSCs do not stay in the lung, but rather release rich compounds that decrease inflammation and promote tissue regeneration. Despite extensive research on MSCs, the exact way that they regenerate the lung is not clear. MSCs can communicate with cells in the lung by releasing extracellular vesicles (EVs), which can be thought of as “care packages”. EVs are small, membrane-bound particles containing bioactive compounds. Lung cells also release EVs, which tells us how they are responding to “care packages” sent by MSCs. Lung cell EVs can be isolated from tracheal aspirates, which are a type of easily accessible biofluid. By looking at molecules carried by EVs before and after newborns receive therapeutic MSCs, we can unravel how these cells promote regeneration in the premature lung to develop better ways of preventing BPD.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506052
Name
Green Mairead
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Extracellular vesicles from tracheal aspirates as novel biomarkers for bronchopulmonary dysplasia
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Lung Injury; Biomarkers; Bronchopulmonary Dysplasia; Clinical Translation; Extracellular Vesicles; Lung Injury; Mesenchymal Stromal Cells; Neonatal; Prematurity
Abstract
Premature infants have underdeveloped lungs, so supplemental oxygen and mechanical ventilation are required to keep them alive. These life-saving interventions cause inflammation and tissue damage in the lungs. This leads to bronchopulmonary dysplasia (BPD), a chronic lung disease of prematurity for which there are no effective treatments. Mesenchymal stromal cells (MSCs) are a type of adult stem cell that are investigated for their therapeutic effect in many diseases. Studies in animals like mice, rats, and pigs have shown that MSCs are safe, work well, and improve lung injury in models of BPD. The HULC-1 trial (Helping Underdeveloped Lungs with Cells-1) evaluates the safety and feasbility of mesenchymal stromal cells (MSCs) for prevention of BPD. MSCs do not stay in the lung, but rather release rich compounds that decrease inflammation and promote tissue regeneration. Despite extensive research on MSCs, the exact way that they regenerate the lung is not clear. MSCs can communicate with cells in the lung by releasing extracellular vesicles (EVs), which can be thought of as “care packages”. EVs are small, membrane-bound particles containing bioactive compounds. Lung cells also release EVs, which tells us how they are responding to “care packages” sent by MSCs. Lung cell EVs can be isolated from tracheal aspirates, which are a type of easily accessible biofluid. By looking at molecules carried by EVs before and after newborns receive therapeutic MSCs, we can unravel how these cells promote regeneration in the premature lung to develop better ways of preventing BPD.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Green, Mairead
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~